Morphine glucuronide

DB06409InvestigationalSmall molecule

Investigated for use/treatment in pain (acute or chronic).

Chemical structure of Morphine glucuronide
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in pain (acute or chronic).Curator reviewed
Formula / weight
C23H27NO9 · 461.4618 g/mol (avg)
Code names
CEE 04-410

Resolves to

Structure
InChIKeyGNJCUHZOSOYIEC-GAROZEBRSA-NSMILES[H][C@]12C=C[C@H](O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4O

What you can answer from here — as of January 29, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Morphine glucuronide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account